As we emerge, in a manner of speaking, from lockdowns and closed borders there are three vital questions. First, does 'escape from the bubble' mean the full restoration of liberties we took for granted in the pre-Covid world? Second, what path will see us pull off this escape? Third, how can we retain the freedom that has been promised?

Read More

Surprisingly, the reasons given by the TGA for the decision forbidding physicians prescribing ivermectin isn't the usual 'unproven', this based on a highly dubious and incomplete survey of the literature. No, it is because widespread use of a cheap, off-patent treatment 'may interfere with the vaccination programme'. What a brazen admission of the bureaucrats' real motive for foiling the use of a much needed drug

Read More

Professor Robert Clancy, a practising clinical immunologist, presents three difficult but important questions related to our future with COVID-19. First, what does 'escape from the bubble', a term favoured by chief medical officers and politicians, actually mean? Second, what is the path to that goal of a pre-COVID normality? Third, how can we regain and retain this freedom?

Read More

In an article in Quadrant Online in January this year, twelve months into a pandemic with a level of devastation unknown to our generation, I described Australia as an island nation, isolated in an artificial and unstable bubble from a sea of COVID-19 causing 15,000 deaths across the world each day. At that time Australia […]

Read More

It is unlikely Australia will see the levels of post-vaccine complications witnessed in the US and Europe as the the low incidence of infection here means widespread priming of the immune system has not happened. The second injections and future booster shots, however, raise the disturbing prospect of very different outcomes. Scandalously, all this while two cheap, proven and effective drugs are spurned

Read More

This not the time for those who should know better to publicly argue for one or other COVID-19 vaccine, not when full and adequate evidence for any such choice is well down the line. What the current moment most definitely does demand is early treatment, especially for the aged and most vulnerable, and for this two cheap, proven and off-patent drugs are readily available -- hydroxychloroquine and ivermectin

Read More